Candace Andersson

655 total citations
19 papers, 529 citations indexed

About

Candace Andersson is a scholar working on Psychiatry and Mental health, Neurology and Cognitive Neuroscience. According to data from OpenAlex, Candace Andersson has authored 19 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 4 papers in Neurology and 4 papers in Cognitive Neuroscience. Recurrent topics in Candace Andersson's work include Schizophrenia research and treatment (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Bipolar Disorder and Treatment (3 papers). Candace Andersson is often cited by papers focused on Schizophrenia research and treatment (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Bipolar Disorder and Treatment (3 papers). Candace Andersson collaborates with scholars based in United States, United Kingdom and Germany. Candace Andersson's co-authors include Michael Tytell, Judy K. Brunso‐Bechtold, K.E. Vanover, Uli Hacksell, N. T. Nash, David M. Weiner, Susan G. Silva, Mark R. Brann, Glenn Croston and Simon C. Harvey and has published in prestigious journals such as Neurology, Brain Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Candace Andersson

19 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candace Andersson United States 10 212 191 162 106 75 19 529
Silvia Diekmann Germany 11 241 1.1× 112 0.6× 151 0.9× 152 1.4× 80 1.1× 11 545
Ruth Henteleff United States 9 232 1.1× 129 0.7× 151 0.9× 123 1.2× 33 0.4× 12 489
Gianmarco Latte Italy 12 233 1.1× 221 1.2× 184 1.1× 121 1.1× 33 0.4× 20 555
Jiaqian Ren United States 12 208 1.0× 76 0.4× 216 1.3× 105 1.0× 33 0.4× 18 546
S. da Costa Araújo United Kingdom 7 343 1.6× 276 1.4× 172 1.1× 73 0.7× 73 1.0× 10 773
Marion Lautenschlager Germany 11 204 1.0× 158 0.8× 180 1.1× 72 0.7× 23 0.3× 17 608
Yohtaro Numachi Japan 15 439 2.1× 309 1.6× 269 1.7× 222 2.1× 57 0.8× 33 876
Masamichi Yokokura Japan 16 300 1.4× 149 0.8× 248 1.5× 147 1.4× 246 3.3× 29 906
Jim Myers United Kingdom 14 305 1.4× 85 0.4× 148 0.9× 204 1.9× 64 0.9× 18 611
Dana Most United States 9 109 0.5× 66 0.3× 143 0.9× 143 1.3× 53 0.7× 11 495

Countries citing papers authored by Candace Andersson

Since Specialization
Citations

This map shows the geographic impact of Candace Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace Andersson more than expected).

Fields of papers citing papers by Candace Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candace Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace Andersson. The network helps show where Candace Andersson may publish in the future.

Co-authorship network of co-authors of Candace Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Candace Andersson. A scholar is included among the top collaborators of Candace Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace Andersson. Candace Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Grossberg, George T., et al.. (2024). Efficacy and Safety Of AXS-05 in Agitation Associated with Alzheimer's Disease: Results From ACCORD, a Phase 3, Double-Blind, Placebo-Controlled, Relapse Prevention Trial. American Journal of Geriatric Psychiatry. 32(4). S94–S95. 1 indexed citations
2.
3.
Johansson, Sara Ellinor, et al.. (2019). Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model. Drug Delivery. 26(1). 680–688. 4 indexed citations
4.
Espay, Alberto J., James C. Norton, Bruce Coate, et al.. (2018). Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications. Movement Disorders. 33(11). 1769–1776. 37 indexed citations
5.
Weintraub, Daniel, James J. S. Norton, Bruce Coate, et al.. (2018). 122 Use of Pimavanserin in Patients With Parkinson’s Disease Psychosis: Subgroup Analysis of Efficacy and Safety in Patients With and Without Cognitive Impairment. CNS Spectrums. 23(1). 77–77. 3 indexed citations
6.
Larhed, Mats & Candace Andersson. (2013). Metal-Catalyzed Heck-Type reactions and C-C cross coupling via C-H activation. Thieme eBooks. 5 indexed citations
7.
Findling, Robert L., Eric A. Youngstrom, Joan Zhao, et al.. (2012). Respondent and item level patterns of response of aripiprazole in the acute treatment of pediatric bipolar I disorder. Journal of Affective Disorders. 143(1-3). 231–235. 6 indexed citations
8.
Robb, Adelaide S., Candace Andersson, Elizabeth E. Bellocchio, et al.. (2011). Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder in Pediatric Subjects (6–17 Years Old). The Primary Care Companion For CNS Disorders. 13(1). 27 indexed citations
9.
Steffens, David C., J. Craig Nelson, James M. Eudicone, et al.. (2010). Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis. International Journal of Geriatric Psychiatry. 26(6). 564–572. 34 indexed citations
10.
Vanover, K.E., Simon C. Harvey, Susan B. Powell, et al.. (2003). ACP-103, A 5-HT2A receptor inverse agonist, a novel potential treatment for psychosis. Schizophrenia Research. 60(1). 317–317. 1 indexed citations
11.
Andersson, Candace. (2002). Striatal Volume Changes in the Rat Following Long-term Administration of Typical and Atypical Antipsychotic Drugs. Neuropsychopharmacology. 27(2). 143–151. 92 indexed citations
12.
Hartman, Marilyn, et al.. (2002). Wisconsin Card Sorting Test performance in schizophrenia: the role of working memory. Schizophrenia Research. 63(3). 201–217. 48 indexed citations
13.
Weiner, David M., Ethan S. Burstein, N. T. Nash, et al.. (2001). 5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics. Journal of Pharmacology and Experimental Therapeutics. 299(1). 268–276. 169 indexed citations
14.
Andersson, Candace, Miranda Chakos, Richard B. Mailman, & Jeffrey A. Lieberman. (1998). EMERGING ROLES FOR NOVEL ANTIPSYCHOTIC MEDICATIONS IN THE TREATMENT OF SCHIZOPHRENIA. Psychiatric Clinics of North America. 21(1). 151–179. 19 indexed citations
15.
Andersson, Candace, Judy K. Brunso‐Bechtold, & Michael Tytell. (1994). Immunocytochemical and ultrastructural characterization of type 1 astrocytes and 0-2A lineage cells in long-term co-cultures. Brain Research. 646(1). 100–117. 11 indexed citations
16.
Eckenstein, F., et al.. (1994). Chapter 6 Distribution of acidic and basic fibroblast growth factors in the mature, injured and developing rat nervous system. Progress in brain research. 55–64. 30 indexed citations
17.
Andersson, Candace, Michael Tytell, & Judy K. Brunso‐Bechtold. (1993). Transplantation of cultured type 1 astrocyte cell suspensions into young, adult and aged rat cortex: Cell migration and survival. International Journal of Developmental Neuroscience. 11(5). 555–568. 37 indexed citations
18.
Puente, Antonio E. & Candace Andersson. (1987). Schizophrenic thinking and neuroleptic dosage. Journal of Clinical Psychology. 43(2). 189–197. 1 indexed citations
19.
Andersson, Candace, et al.. (1984). Self-Consciousness in Acute and Chronic Schizophrenics. Psychological Reports. 55(2). 569–570. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Diekmann Breakdown of academic impact, for papers by Ruth Henteleff Breakdown of academic impact, for papers by Gianmarco Latte Breakdown of academic impact, for papers by Jiaqian Ren Breakdown of academic impact, for papers by S. da Costa Araújo Breakdown of academic impact, for papers by Marion Lautenschlager Breakdown of academic impact, for papers by Yohtaro Numachi Breakdown of academic impact, for papers by Masamichi Yokokura Breakdown of academic impact, for papers by Jim Myers Breakdown of academic impact, for papers by Dana Most
Rankless by CCL
2026